General Information of the Compound
Compound ID
CP0139390
Compound Name
N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide
    Show/Hide
Synonyms
1056634-68-4
6O01GMS00P
AK102858
CHEMBL1078178
CYT 11387
CYT 387
CYT387 sulfate salt
Cyt-387
Cyt387
MOMELOTINIB
Momelotinib
N-(Cyanomethyl)-4-(2-((4-morpholinophenyl)-amino)pyrimidin-4-yl)benzamide
N-(Cyanomethyl)-4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzamide
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide
UNII-6O01GMS00P
    Show/Hide
Structure
Formula
C23H22N6O2
Molecular Weight
414.469
Canonical SMILES
O=C(NCC#N)c1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1
    Show/Hide
InChI
InChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)
    Show/Hide
InChIKey
ZVHNDZWQTBEVRY-UHFFFAOYSA-N
CAS
1056634-68-4
Physicochemical Property
logP
2.97718
Rotatable Bonds
6
Heavy Atom Count
31
Polar Areas
103.17
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25062766
SID: 56399705
ChEMBL ID
CHEMBL1078178
DrugBank ID
DB11763
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04886, Tyrosine-protein kinase JAK2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Momelotinib )
Drug Name Momelotinib
Company GSK
Indication
Myelofibrosis
Phase 3
Polycythemia vera
Phase 2
Thrombocythemia
Phase 2
Target(s)
Janus kinase 2 (JAK-2)
Modulator
Janus kinase 1 (JAK-1)
Modulator